PFE vs QCOM: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and QUALCOMM Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.

PFE

Pfizer Inc. · Healthcare

$25.22

+2.8% upside to fair value

Grade B

QCOM

QUALCOMM Incorporated · Technology

$226.11

-10.7% upside to fair value

Grade D High Quality

QuantHub Verdict

PFE has more upside to fair value (+2.8%). PFE trades at a lower forward P/E (19.2x). These are model outputs — not personalized investment advice. See all research →

Valuation & Fundamentals

Metric	PFE	QCOM
Current Price	$25.22	$226.11
Fair Value Estimate	$25.92	$201.84
Upside to Fair Value	+2.8%	-10.7%
Market Cap	$143.7B	$238.3B
Forward P/E	19.2x	24.3x
EV / EBITDA	12.3x	17.5x
Price / Sales	2.3x	5.4x
Price / FCF	15.2x	19.1x
Revenue Growth YoY	+5.4%	-3.5%
Gross Margin	69.3%	54.8%
Operating Margin	23.4%	25.5%
Return on Equity	8.4%	40.2%
Dividend Yield	0%	0%
FCF Yield	6.6%	5.25%
Analyst Consensus	Hold	Hold

Investment Thesis

PFE — Pfizer Inc.

Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…

QCOM — QUALCOMM Incorporated

Qualcomm Incorporated is a leading semiconductor and telecommunications equipment company specializing in cellular and RF technologies, with a strong competitive moat driven by its intellectual property and scale in premium Android and 5G modems. The company benefits from a long-tenured management team and a diversified business model expanding into automotive, IoT, and computing sectors. Despite…

Accumulation Zones

Metric	PFE	QCOM
Zone Low	$19.44	$151.38
Zone High	$22.03	$171.56
In Buy Zone?	No	No

← PFE Research QCOM Research → All Research